SCHEMBL6964073

SCHEMBL6964073

Cc1ccc(-c2cc(O)c(Sc3ccccc3C(C)C)c(=O)o2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
TNKS O95271 2/20 0.41
PARP1 P09874 2/20 0.41
TNKS2 Q9H2K2 2/20 0.41
PARP2 Q9UGN5 2/20 0.41
MAOB P27338 1/20 0.41
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
KDM4E B2RXH2 3/20 0.40
HDAC6 Q9UBN7 1/20 0.39
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
ABCB1 P08183 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963494 0.92 PTGES (0.43) ARTNKSPARP1TNKS2PARP2
SCHEMBL6961039 0.91 SMN1; SMN2 (0.46) ARTNKSPARP1TNKS2PARP2
SCHEMBL6959292 0.91 POLB (0.35) ARTNKSPARP1TNKS2PARP2
SCHEMBL6954281 0.89 ALDH1A1 (0.42) ARTNKSPARP1TNKS2PARP2
SCHEMBL6960601 0.89 AR (0.41) ARTNKSPARP1TNKS2PARP2
SCHEMBL6961237 0.88 QPCT (0.42) TNKSPARP1TNKS2MAOBKDM4E
SCHEMBL6960294 0.88 QPCT (0.39) TNKSPARP1TNKS2PARP2HDAC6
SCHEMBL6954542 0.87 L3MBTL1 (0.47) ARTNKSPARP1TNKS2PARP2
SCHEMBL6961094 0.87 NTRK1 (0.49) TNKSTNKS2MAOBCDK8KDM4E
SCHEMBL6959070 0.87 POLB (0.42) ARTNKSPARP1TNKS2PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed